Chai Discovery: $70 Million Series A Raised For Reprogramming Interactions Between Biochemical Molecules
By Amit Chowdhry ● Aug 7, 2025
Chai Discovery, an AI company specializing in predicting and reprogramming biochemical interactions to accelerate the development of therapeutics, has raised $70 million in a Series A financing round. The funding, led by Menlo Ventures with participation from their Anthology Fund, included new investors such as Yosemite and DCVC, as well as existing backers like Thrive Capital, OpenAI, and Dimension.